EUVIMEDEUVIMED entdecken
Crossref

Mucosal vaccination clears Clostridioides difficile colonization 2257244

Audrey Thomas

The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)

DOI: 10.1093/jimmun/vkag141.408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Audrey Thomas.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Clostridioides difficile infection (CDI) is a leading cause of healthcare-associated infections in the United States. Recent vaccine strategies targeting the toxins responsible for CDI symptoms were unsuccessful in reducing C. difficile colonization in Phase III clinical trials. Colonization prevention or bacterial clearance would eliminate transmission of C. difficile spores and forestall recurrent CDI. Therefore, new vaccination strategies aim to identify novel surface antigens that promote mucosal immunity and bacterial clearance.

Methods

To start, we immunized mice with four candidate surface antigens by both parenteral and mucosal routes of administration and challenged with C. difficile. Three of these antigens reduced colonization burden in vivo, but only when administered by mucosal vaccination. We then immunized mice with a formula containing the three effective surface antigens and inactivated C. difficile toxins, again using both routes of administration.

Results

Both immunization routes protected against epithelial tissue damage, weight loss, and mortality. The mice that received mucosal immunization cleared both spores and vegetative bacteria, which was confirmed via tissue and fecal qPCR. However, those that received parenteral immunization were unable to do so, despite a robust systemic humoral response. We did not detect anti-surface-antigen systemic IgG nor fecal IgA in mice that received mucosal vaccination. Correlates of decolonization included fecal IgG responses to vegetative surface antigens, which reduce bacterial mobility, and a colonic, Th17-skewed tissue-resident memory T cell response against spore antigen.

Conclusion

We have demonstrated, for the first time, the clearance of C. difficile from the host after mucosal immunization. Our results demarcate notable differences in correlates of protection and pathogen clearance between administration routes and highlight mucosal immunization as the paramount strategy to elicit sterilizing immunity against CDI. Funding Source National Institutes of Health grant U19 AI174999 (my PI) Topic Categories Vaccines and Immunotherapy (VAC)

Zitieren

APA

Thomas, A. (2026). Mucosal vaccination clears Clostridioides difficile colonization 2257244. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.408

Vancouver

Thomas A. Mucosal vaccination clears Clostridioides difficile colonization 2257244. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.408

BibTeX
@article{Thomas2026,
  author = {Thomas, Audrey},
  title = {Mucosal vaccination clears Clostridioides difficile colonization 2257244},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {Supplement_1},
  doi = {10.1093/jimmun/vkag141.408}
}
Kostenlos starten →